These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Intermittent acute porphyria. Clinical and biochemical studies of disordered heme biosynthesis. Meyer UA Enzyme; 1973; 16(1):334-42. PubMed ID: 4791052 [No Abstract] [Full Text] [Related]
26. [Pathophysiology and diagnosis of acute intermittent porphyria]. Wichmann T; Freye HA Z Gesamte Inn Med; 1977 Jun; 32(12):289-92. PubMed ID: 910533 [TBL] [Abstract][Full Text] [Related]
27. [Normal activity of uroporphyrinogen I synthase during an attack of acute intermittent porphyria]. Kostrzewska E; Gregor A Pol Tyg Lek; 1980 Nov; 35(46):1785-6. PubMed ID: 7243643 [No Abstract] [Full Text] [Related]
28. Congenital erythropoietic porphyria with a hitherto undescribed porphyrin pattern. Hofstad F; Seip M; Eriksen L Acta Paediatr Scand; 1973 Jul; 62(4):380-4. PubMed ID: 4729688 [No Abstract] [Full Text] [Related]
30. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria]. Iwanov ED; Adjarov D; Tsanev R Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585 [TBL] [Abstract][Full Text] [Related]
31. New form of dual porphyria: coexistent acute intermittent porphyria and porphyria cutanea tarda. Doss MO Eur J Clin Invest; 1989 Feb; 19(1):20-5. PubMed ID: 2499457 [TBL] [Abstract][Full Text] [Related]
32. The effects of chronic carbamazepine treatment of haem biosynthesis in man and rat. McGuire GM; Macphee GJ; Thompson GG; Park BK; Moore MR; Brodie MJ Eur J Clin Pharmacol; 1988; 35(3):241-7. PubMed ID: 3181278 [TBL] [Abstract][Full Text] [Related]
33. -aminolevulinic acid synthetase activity in human plasma: relation to erythropoiesis and evidence of induction in erythropoietic porphyria. Miyagi K; Watson CJ Blood; 1972 Jan; 39(1):13-22. PubMed ID: 4536663 [No Abstract] [Full Text] [Related]
34. Deficient induction of uroporphyrinogen-I synthase activity in mitogen-stimulated lymphocytes from patients with acute intermittent porphyria. Sassa S; Zalar GL; Kappas A Trans Assoc Am Physicians; 1977; 90():157-66. PubMed ID: 611660 [No Abstract] [Full Text] [Related]
35. A review of the enzymic errors in the various porphyrias. Rimington C Scand J Clin Lab Invest; 1985 Jun; 45(4):291-301. PubMed ID: 3892647 [No Abstract] [Full Text] [Related]
36. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Doss M; von Tiepermann R; Schneider J; Schmid H Klin Wochenschr; 1979 Oct; 57(20):1123-7. PubMed ID: 513604 [TBL] [Abstract][Full Text] [Related]
37. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity. Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768 [TBL] [Abstract][Full Text] [Related]
38. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria. Kostrzewska E; Gregor A Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651 [TBL] [Abstract][Full Text] [Related]
39. Congenital erythropoietic porphyria. A case report with discussion of different porphyrin excretion patterns. Dahle JS; Eriksen L; Romslo I; Thune P Photodermatol; 1984 Aug; 1(4):187-90. PubMed ID: 6531292 [TBL] [Abstract][Full Text] [Related]
40. Lack of effect of pregnancy or hematin therapy on erythrocyte porphobilinogen deaminase activity in acute intermittent porphyria. Sassa S; Kappas A N Engl J Med; 1989 Jul; 321(3):192-3. PubMed ID: 2747754 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]